Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Human Subject Protection Systems At Five Universities Under Review By GAO

Executive Summary

The General Accounting Office is visiting five of the top 10 federally funded public and private research universities to review their systems for protecting human research subjects and handling conflict of interest issues.

You may also be interested in...



GAO Financial Conflict Of Interest Report Planned For Mid-July

The General Accounting Office plans to issue a report on financial conflict of interest in clinical research in mid-July.

GAO Financial Conflict Of Interest Report Planned For Mid-July

The General Accounting Office plans to issue a report on financial conflict of interest in clinical research in mid-July.

FDA Surveillance of Financial Conflict Of Interest Needs To Increase - Henney

Increased surveillance of financial conflict of interest is needed to guard against even a perception of bias by the public, FDA Commissioner Henney indicated during HHS' meeting on human subject protection and financial conflict of interest Aug. 15 at NIH.

Related Content

UsernamePublicRestriction

Register

PS037393

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel